Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 4 of 4 for “"Spravato"”.

  1. Modulating Ketamine’s Locomotor Activating and Reinforcing Effects Through Drug Combinations

    … (S)-ketamine was approved as a nasal spray (Spravato®) for patients with MDD and treatment-resistant depression in conjunction with their previously prescribed MAAs. However, ketamine has limitations of its own, such as producing sedation and dissociative effects as well as having known abuse …

    vcu Repository record for Modulating Ketamine’s Locomotor Activating and Reinforcing Effects Through Drug Combinations (opens in a new tab)

  2. Effects of (R,S)-ketamine and (2R,6R)-hydroxynorketamine: a preclinical study

    … FDA approved (S) ketamine (esketamine, Ketanest, Spravato) for treatment-resistant depression in March 2019. Excitement for a better treatment, however, is lessened by reports indicating that some patients may experience severe side effects like reduced cognitive functioning a day or more after …

    vcu Repository record for Effects of (R,S)-ketamine and (2R,6R)-hydroxynorketamine: a preclinical study (opens in a new tab)

  3. Intranasales Esketamin zur Behandlung der akuten Depression

    Fragestellung: Reduziert intranasales Esketamin, ergänzend zur Regelbehandlung, schwere depressive Symptome einhergehend mit akuter Suizidalität innerhalb von 24 Stunden und hält ein etwaiger Effekt mittelfristig an? Methodik: Die hier analysierten Daten wurden im Rahmen einer doppelblinden, …

    fu-berlin Repository record for Intranasales Esketamin zur Behandlung der akuten Depression (opens in a new tab)

  4. Ketamine: a feasible replacement for current major depressive disorder therapies

    Major depressive disorder (MDD) is among the most common mental health problems in the U.S. and the world. A significant portion of patients with MDD do not respond to current antidepressant medications and are considered treatment-resistant. Current antidepressant therapies have a late onset of …

    bu Repository record for Ketamine: a feasible replacement for current major depressive disorder therapies (opens in a new tab)